George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 15,000 shares at $371.98 ($5.6M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Seasonal sale ($5.6M) by Director — this insider has traded REGN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |